← Browse by Condition
Medical Condition
nasopharangeal cancer
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 3
NCT07392320 Phase 2
Recruiting
A Phase II Trial Comparing Immunotherapy Versus Capecitabine Maintenance After Chemo-chemoradiotherapy for High-risk Nasopharyngeal Carcinoma
Enrollment
142 pts
Location
China
Sponsor
Sun Yat-sen University
NCT07235319 Phase 3
Recruiting
PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC
Enrollment
260 pts
Location
China
Sponsor
Sun Yat-sen University